ADVANCED NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer immune cell therapy study stopped early after just 2 patients
Disease control TerminatedThis study tested a treatment called GT201, which uses immune cells taken from a patient's own tumor to attack advanced lung cancer. It was designed for adults aged 18-70 with non-small cell or small cell lung cancer that had stopped responding to standard treatments. The study w…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Lung cancer drug trial halted early: what we know
Disease control TerminatedThis early-stage trial tested a new drug called MYTX-011 for people with advanced non-small cell lung cancer (NSCLC) that had spread or come back after standard treatments. The drug is an antibody-drug conjugate designed to deliver a powerful chemotherapy directly to cancer cells…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Mythic Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC